Slovenian genomics firm GenePlanet attracts strategic investment from Lauxera Capital Partners
Slovenian genomics and laboratory company GenePlanet secured a strategic investment from Lauxera Capital Partners. The deal also saw early investor BlackPeak Capital partially exit while staying on the cap table, providing GenePlanet with additional capital to expand its genetic testing and next‑generation sequencing services across Europe.